--- title: "KNSA.US (KNSA.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/KNSA.US/news.md" symbol: "KNSA.US" name: "KNSA.US" parent: "https://longbridge.com/en/quote/KNSA.US.md" datetime: "2026-05-20T06:52:46.207Z" locales: - [en](https://longbridge.com/en/quote/KNSA.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/KNSA.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/KNSA.US/news.md) --- # KNSA.US (KNSA.US) — Related News ### [Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Strong Q1 Results And Raised Revenue Guidance](https://longbridge.com/en/news/285144274.md) *2026-05-05T02:13:45.000Z* > Kiniksa Pharmaceuticals (KNSA) reported Q1 2026 results with revenue of $214.27 million and net income of $22.59 million ### [Kornitzer Capital Management Inc. KS Purchases New Shares in Kiniksa Pharmaceuticals International, plc $KNSA](https://longbridge.com/en/news/285057635.md) *2026-05-04T10:29:32.000Z* > Kornitzer Capital Management Inc. KS acquired a new stake in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) du ### [Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor](https://longbridge.com/en/news/284944421.md) *2026-05-01T21:55:28.000Z* > Kiniksa Pharmaceuticals announced the resignation of Chief Strategy Officer Eben Tessari, effective May 15, 2026, to pur ### [Kiniksa Pharmaceuticals’ Mine Safety Disclosure: No Incidents Reported but Transparency Gaps Remain for Investors](https://longbridge.com/en/news/284709491.md) *2026-04-30T06:00:10.000Z* > Kiniksa Pharmaceuticals Ltd. Class A (KNSA) has reported no incidents in its mine safety disclosures, indicating limited ### [Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today](https://longbridge.com/en/news/284462600.md) *2026-04-28T23:35:19.000Z* > Kiniksa Pharmaceuticals International (NASDAQ: KNSA) saw its stock surge nearly 24% after releasing its inaugural 2026 e ### [Top 10 US Stock Gainers (4.28)](https://longbridge.com/en/news/284455327.md) *2026-04-28T22:01:01.000Z* > Kforce.com(KFRC) rose 43.3%, with a trading turnover 79.1 Million USD, and a year-to-date rose 50.5%. Kiniksa Pharmaceut ### [Morning News Wrap-Up, 4/28/26: Today's Biggest Stock Market Stories!](https://longbridge.com/en/news/284430404.md) *2026-04-28T17:37:14.000Z* > Investors are focused on key stock market stories today. Nexera Technologies (NEXR) shares soared after a subsidiary dea ### [Lorusso Lifts Price Target to $65 and Reiterates Buy on Strong Arcalyst Momentum and Upside Potential](https://longbridge.com/en/news/284429058.md) *2026-04-28T16:35:26.000Z* > Analyst Nicholas Lorusso from TD Cowen has reiterated a Buy rating on Kiniksa Pharmaceuticals, raising the price target ### [](https://longbridge.com/en/news/284268258.md) *2026-04-27T20:34:06.000Z* > Crane shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY20